- Home
- RIGL vs CLCO Comparison
RIGL vs CLCO Comparison
Compare RIGL & CLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- CLCO
- Stock Information
- Founded
- RIGL 1996
- CLCO 2018
- Country
- RIGL United States
- CLCO United Kingdom
- Employees
- RIGL N/A
- CLCO N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- CLCO
- Sector
- RIGL Health Care
- CLCO
- Exchange
- RIGL Nasdaq
- CLCO Nasdaq
- Market Cap
- RIGL 486.4M
- CLCO 417.5M
- IPO Year
- RIGL 2000
- CLCO N/A
- Fundamental
- Price
- RIGL $20.99
- CLCO $8.41
- Analyst Decision
- RIGL Buy
- CLCO
- Analyst Count
- RIGL 5
- CLCO 0
- Target Price
- RIGL $34.80
- CLCO N/A
- AVG Volume (30 Days)
- RIGL 216.6K
- CLCO 148.3K
- Earning Date
- RIGL 03-04-2025
- CLCO 02-26-2025
- Dividend Yield
- RIGL N/A
- CLCO 7.17%
- EPS Growth
- RIGL N/A
- CLCO N/A
- EPS
- RIGL 0.22
- CLCO 1.73
- Revenue
- RIGL $157,374,000.00
- CLCO $333,653,000.00
- Revenue This Year
- RIGL $51.34
- CLCO N/A
- Revenue Next Year
- RIGL $15.75
- CLCO $2.93
- P/E Ratio
- RIGL $94.25
- CLCO $4.87
- Revenue Growth
- RIGL 21.65
- CLCO N/A
- 52 Week Low
- RIGL $7.48
- CLCO $6.92
- 52 Week High
- RIGL $29.82
- CLCO $13.68
- Technical
- Relative Strength Index (RSI)
- RIGL 55.77
- CLCO 50.25
- Support Level
- RIGL $20.98
- CLCO $8.30
- Resistance Level
- RIGL $23.01
- CLCO $8.77
- Average True Range (ATR)
- RIGL 1.40
- CLCO 0.25
- MACD
- RIGL 0.31
- CLCO -0.00
- Stochastic Oscillator
- RIGL 70.13
- CLCO 26.11
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About CLCO Cool Company Ltd.
Cool Co Ltd is a LNG shipping company. The company is engaged in the acquisition, ownership, operation and chartering of liquefied natural gas (LNG) carriers (LNGCs), and the operation of third party fleets under management agreements.